PAHC — Phibro Animal Health Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual income statement for Phibro Animal Health, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	942	978	1,018	1,296	1,518
Cost of Revenue
Gross Profit	285	298	314	409	506
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	863	906	964	1,186	1,324
Operating Profit	79	71.8	53.3	110	194
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	72.3	54.1	10.9	68	137
Provision for Income Taxes
Net Income After Taxes	49.2	32.6	2.42	48.3	99.7
Net Income Before Extraordinary Items
Net Income	49.2	32.6	2.42	48.3	99.7
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	49.2	32.6	2.42	48.3	99.7
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.22	0.908	0.401	1.66	2.43
Dividends per Share